| payload |
{"created_at":"2026-04-15T02:18:53.247 {"created_at":"2026-04-15T02:18:53.247056+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:de2db4fdee0027e8","evidence_event_ids":["evt_7021814c89ec"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1829802/0001238120-26-000006.txt","as_of":"2026-04-15T02:18:53.247056+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1829802/0001238120-26-000006.txt","company":"Sensei Biotherapeutics, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1829802/0001238120-26-000006.txt","article_chars":3062,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_3feda39150b8162e","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1829802/0001238120-26-000006.txt","content_type":"text/plain","enriched_at":"2026-04-15T06:48:22.428078+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1829802/0001238120-26-000006.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1829802/0001238120-26-000006.txt","source_event_id":"evt_7021814c89ec","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"c380eebd8522b2d4","kind":"sec_filing","published_at":"20260414","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-15T02:18:53.247056+00:00"],"entities":[{"asset_class":"equity","name":"Sensei Biotherapeutics, Inc.","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"person","name":"Christopher Gerry","relevance":"high","symbol":"","type":"attorney-in-fact"},{"asset_class":"person","name":"Josiah Craver","relevance":"high","symbol":"","type":"attorney-in-fact"}],"event_type":"listing","information_gaps":["The provided text does not include the actual Form 4 transaction details (e.g., number of shares, security title, transaction type, dates, or price).","The specific undersigned person (the reporting insider) is not named in the provided excerpt.","The excerpt does not state the exact execution date written below the Power of Attorney."],"key_facts":["The document is a Power of Attorney for executing Forms 3, 4, and 5.","The undersigned appoints Christopher Gerry and Josiah Craver of Sensei Biotherapeutics, Inc. as attorneys-in-fact to prepare, execute, and submit Forms 3, 4, and 5 to the SEC.","The authority is granted for Section 16(a) compliance for the undersigned\u2019s capacity as an officer, director, or beneficial owner of more than 10% of a registered class of securities.","The attorneys-in-fact are authorized to take actions necessary or desirable to execute and timely file the forms, including amendments.","The undersigned grants full power and authority to act, including with full power of substitution or revocation.","The document states that the attorneys-in-fact (and the Company) are not assuming responsibilities to comply with Section 16 of the Exchange Act.","The Power of Attorney remains in effect until the undersigned is no longer required to file Forms 3, 4, and 5, unless revoked, or until the attorney-in-fact is no longer employed by the Company."],"numeric_claims":[],"primary_claim":"The Form 4 filing contains a Power of Attorney appointing Christopher Gerry and Josiah Craver to prepare, execute, and file Forms 3, 4, and 5 for Section 16(a) compliance.","relevance_score":0.35,"sentiment":"neutral","source_quality":"high","summary":"Sensei Biotherapeutics, Inc. filed a Form 4 that includes a Power of Attorney authorizing specific individuals to prepare, execute, and submit Forms 3, 4, and 5 on behalf of the undersigned under Section 16(a). The filing text provided does not include the underlying Form 4 transaction details.","topics":["SEC Form 4","Power of Attorney","Section 16(a)","Forms 3, 4, and 5","insider reporting"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 Sensei Biotherapeutics, Inc. \u00b7 Filed 20260414","ticker":"SNSE","tickers":["SNSE"],"title":"SNSE filed 4","url":"https://www.sec.gov/Archives/edgar/data/1829802/0001238120-26-000006.txt"}}... |